Sarah Cannon Research Institute-Nashville-48456 — Nashville, Tennessee

Sarah Cannon Research Institute-Nashville-48456 is a clinical research site located in Nashville, Tennessee, United States 37203.

Crixeo Clinical Trials Trust Score: 11/100 (FAILING). This profile has not yet been claimed by the site owner.

Sarah Cannon Research Institute-Nashville-48456 has participated in 2 clinical trials with 2 currently active.

Therapeutic areas: Solid Tumors, KRAS Mutation; SOS1, Neoplasm Metastasis, Non-Small Cell Lung Cancer.

Sponsors: Boehringer Ingelheim.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Nashville

Browse all research sites in Tennessee · View every site in Nashville

Sponsor Feasibility Report

Trust Score: 11/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Sarah Cannon Research Institute-Nashville-48456?

Sarah Cannon Research Institute-Nashville-48456 has a Crixeo Trust Score of 11/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Sarah Cannon Research Institute-Nashville-48456 conducted?

Sarah Cannon Research Institute-Nashville-48456 has 2 clinical trials on record, with 2 currently active. Their work covers Solid Tumors, KRAS Mutation; SOS1, Neoplasm Metastasis, Non-Small Cell Lung Cancer.

Is Sarah Cannon Research Institute-Nashville-48456 accredited by Crixeo Clinical Trials?

Sarah Cannon Research Institute-Nashville-48456 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Sarah Cannon Research Institute-Nashville-48456?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.